Author:
Ebrahimi Narges,Yousefi Zahra,Khosravi Gholamreza,Malayeri Fatemeh Eskandari,Golabi Marjan,Askarzadeh Monireh,Shams Mohammad Hossein,Ghezelbash Behrooz,Eskandari Nahid
Abstract
Human papillomavirus (HPV) is a viral infection that, if does not go away, can cause health problems like genital warts and cancer. The national immunization schedules for individuals before sexual debut, significantly decreased HPV-associated mortality and it will be affordable. However, immunization programs remain vulnerable to macroeconomic factors such as inflation, fiscal policy, employment levels, and national income. This review aims to investigate the association between national income in lower-middle-income countries to explore recent advances and potential issues, as well as how to deal with challenges.
Subject
Immunology,Immunology and Allergy
Reference110 articles.
1. An update on human papilloma virus vaccines: history, types, protection, and efficacy;Yousefi;Front Immunol,2021
2. Mothers’ preferences and willingness-to-pay for human papillomavirus vaccines in Iran: a discrete choice experiment study;Sargazi;Prev Med Rep,2021
3. Epidemiology and burden of human papillomavirus and related diseases, molecular pathogenesis, and vaccine evaluation;Kombe Kombe;Front Public Health,2020
4. Non-sexual HPV transmission and role of vaccination for a better future (Review);Petca;Exp Ther Med,2020
5. Prevalence of human papilloma virus (HPV) genotypes between outpatients males and females referred to seven laboratories in Tehran, Iran;Rezaee Azhar;Infect Agents Cancer,2022
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献